A detailed history of Israel Englander (Millennium Management LLC) transactions in I Mab stock. As of the latest transaction made, Millennium Management LLC holds 11,325 shares of IMAB stock, worth $11,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,325
Previous 40,308 71.9%
Holding current value
$11,098
Previous $67,000 79.1%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.03 - $1.72 $29,852 - $49,850
-28,983 Reduced 71.9%
11,325 $14,000
Q2 2024

Aug 14, 2024

SELL
$1.58 - $1.9 $84,056 - $101,080
-53,200 Reduced 56.89%
40,308 $67,000
Q1 2024

May 15, 2024

SELL
$1.54 - $2.37 $150,601 - $231,769
-97,793 Reduced 51.12%
93,508 $173,000
Q4 2023

Feb 14, 2024

BUY
$1.21 - $1.9 $231,474 - $363,471
191,301 New
191,301 $363,000
Q1 2023

May 15, 2023

BUY
$3.08 - $7.39 $949,025 - $2.28 Million
308,125 Added 80.53%
690,767 $2.39 Million
Q4 2022

Feb 14, 2023

BUY
$3.22 - $4.86 $1.09 Million - $1.65 Million
338,675 Added 770.29%
382,642 $1.6 Million
Q3 2022

Nov 14, 2022

BUY
$4.01 - $12.34 $52,450 - $161,407
13,080 Added 42.35%
43,967 $176,000
Q2 2022

Aug 15, 2022

SELL
$8.27 - $18.43 $1.24 Million - $2.77 Million
-150,466 Reduced 82.97%
30,887 $349,000
Q1 2022

May 16, 2022

BUY
$12.54 - $46.93 $1.41 Million - $5.27 Million
112,374 Added 162.91%
181,353 $2.95 Million
Q4 2021

Feb 14, 2022

BUY
$45.28 - $74.5 $473,176 - $778,525
10,450 Added 17.85%
68,979 $3.27 Million
Q3 2021

Nov 15, 2021

BUY
$57.18 - $84.43 $1.87 Million - $2.76 Million
32,669 Added 126.33%
58,529 $4.24 Million
Q2 2021

Aug 16, 2021

SELL
$47.86 - $83.95 $14.6 Million - $25.5 Million
-304,036 Reduced 92.16%
25,860 $2.17 Million
Q1 2021

May 17, 2021

BUY
$44.38 - $63.97 $13.3 Million - $19.2 Million
299,397 Added 981.66%
329,896 $16 Million
Q4 2020

Feb 16, 2021

BUY
$32.94 - $47.15 $860,491 - $1.23 Million
26,123 Added 596.96%
30,499 $1.44 Million
Q3 2020

Nov 16, 2020

BUY
$27.46 - $47.03 $120,164 - $205,803
4,376 New
4,376 $206,000
Q2 2020

Aug 14, 2020

SELL
$13.0 - $31.0 $223,509 - $532,983
-17,193 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$10.63 - $15.37 $182,761 - $264,256
17,193 New
17,193 $224,000

Others Institutions Holding IMAB

About I-Mab


  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $81.4M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.